These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

977 related articles for article (PubMed ID: 17542627)

  • 21. Novel breast cancer biomarkers identified by integrative proteomic and gene expression mapping.
    Ou K; Yu K; Kesuma D; Hooi M; Huang N; Chen W; Lee SY; Goh XP; Tan LK; Liu J; Soon SY; Bin Abdul Rashid S; Putti TC; Jikuya H; Ichikawa T; Nishimura O; Salto-Tellez M; Tan P
    J Proteome Res; 2008 Apr; 7(4):1518-28. PubMed ID: 18318472
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Proteomic analysis of human ovarian cancer cell lines and their platinum-resistant clones].
    Yan XD; Pan LY
    Zhonghua Fu Chan Ke Za Zhi; 2006 Sep; 41(9):584-7. PubMed ID: 17181965
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Proteome study of colorectal cancer genesis and hepatic metastasis].
    Bai X; Li SY; An P; Yu B; Cai HY
    Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(30):2128-31. PubMed ID: 16313824
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preoperatively molecular staging with CM10 ProteinChip and SELDI-TOF-MS for colorectal cancer patients.
    Xu WH; Chen YD; Hu Y; Yu JK; Wu XG; Jiang TJ; Zheng S; Zhang SZ
    J Zhejiang Univ Sci B; 2006 Mar; 7(3):235-40. PubMed ID: 16502512
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comparative proteomics of the serum in patients with nasopharyngeal carcinoma: a study with two-dimensional electrophoresis and MALDI-TOF-MS].
    Liao QL; Chen XD; Zhao L; Ding YQ
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Feb; 28(2):154-8. PubMed ID: 18250030
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry.
    Yu KH; Rustgi AK; Blair IA
    J Proteome Res; 2005; 4(5):1742-51. PubMed ID: 16212428
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of 5-fluorouracil response proteins in colorectal carcinoma cell line SW480 by two-dimensional electrophoresis and MALDI-TOF mass spectrometry.
    Wong CS; Wong VW; Chan CM; Ma BB; Hui EP; Wong MC; Lam MY; Au TC; Chan WH; Cheuk W; Chan AT
    Oncol Rep; 2008 Jul; 20(1):89-98. PubMed ID: 18575723
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Screening of differentially expressed proteins associated with directional highly lymphatic metastasis in ovarian carcinoma cell lines using SELDI-TOF-MS technology].
    Guan X; Li DR; Wang Q; Li L; Ruan HY; Zhang W
    Ai Zheng; 2008 Nov; 27(11):1155-60. PubMed ID: 19000445
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proteomic analysis of colorectal cancer metastasis: stathmin-1 revealed as a player in cancer cell migration and prognostic marker.
    Tan HT; Wu W; Ng YZ; Zhang X; Yan B; Ong CW; Tan S; Salto-Tellez M; Hooi SC; Chung MC
    J Proteome Res; 2012 Feb; 11(2):1433-45. PubMed ID: 22181002
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Node-negative colorectal cancer at high risk of distant metastasis identified by combined analysis of lymph node status, vascular invasion, and Raf-1 kinase inhibitor protein expression.
    Zlobec I; Baker K; Minoo P; Jass JR; Terracciano L; Lugli A
    Clin Cancer Res; 2008 Jan; 14(1):143-8. PubMed ID: 18172264
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proteome analysis of membrane fractions in colorectal carcinomas by using 2D-DIGE saturation labeling.
    Alfonso P; Cañamero M; Fernández-Carbonié F; Núñez A; Casal JI
    J Proteome Res; 2008 Oct; 7(10):4247-55. PubMed ID: 18707159
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prohibitin identified by proteomic analysis of prostate biopsies distinguishes hyperplasia and cancer.
    Ummanni R; Junker H; Zimmermann U; Venz S; Teller S; Giebel J; Scharf C; Woenckhaus C; Dombrowski F; Walther R
    Cancer Lett; 2008 Aug; 266(2):171-85. PubMed ID: 18384941
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of collapsin response mediator protein-2 as a potential marker of colorectal carcinoma by comparative analysis of cancer cell secretomes.
    Wu CC; Chen HC; Chen SJ; Liu HP; Hsieh YY; Yu CJ; Tang R; Hsieh LL; Yu JS; Chang YS
    Proteomics; 2008 Jan; 8(2):316-32. PubMed ID: 18203259
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proteome analysis and tissue array for profiling protein markers associated with type B thymoma subclassification.
    Sun QL; Fang WT; Feng J; Zhang J; Yang XH; Gu ZT; Zhu L; Sha HF
    Chin Med J (Engl); 2012 Aug; 125(16):2811-8. PubMed ID: 22932072
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proteomic analysis of differentially expressed proteins involving in liver metastasis of human colorectal carcinoma.
    Li SY; An P; Cai HY; Bai X; Zhang YN; Yu B; Zuo FY; Chen G
    Hepatobiliary Pancreat Dis Int; 2010 Apr; 9(2):149-53. PubMed ID: 20382585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Secretomic and proteomic analysis of potential breast cancer markers by two-dimensional differential gel electrophoresis.
    Lai TC; Chou HC; Chen YW; Lee TR; Chan HT; Shen HH; Lee WT; Lin ST; Lu YC; Wu CL; Chan HL
    J Proteome Res; 2010 Mar; 9(3):1302-22. PubMed ID: 20052998
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New prognosis biomarkers identified by dynamic proteomic analysis of colorectal cancer.
    Peng Y; Li X; Wu M; Yang J; Liu M; Zhang W; Xiang B; Wang X; Li X; Li G; Shen S
    Mol Biosyst; 2012 Nov; 8(11):3077-88. PubMed ID: 22996014
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Differential analysis of associated proteome in hepatic fibrosis tissue].
    Luo XH; Yang Q; Zhang Q; Cheng ML
    Zhonghua Yi Xue Za Zhi; 2007 Dec; 87(48):3411-4. PubMed ID: 18476540
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical significance of human kallikrein 10 gene expression in colorectal cancer and gastric cancer.
    Feng B; Xu WB; Zheng MH; Ma JJ; Cai Q; Zhang Y; Ji J; Lu AG; Qu Y; Li JW; Wang ML; Hu WG; Liu BY; Zhu ZG
    J Gastroenterol Hepatol; 2006 Oct; 21(10):1596-603. PubMed ID: 16928223
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proteomic analysis to identify biomarker proteins in pancreatic ductal adenocarcinoma.
    Chung JC; Oh MJ; Choi SH; Bae CD
    ANZ J Surg; 2008 Apr; 78(4):245-51. PubMed ID: 18366394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 49.